Table of Contents
Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, immune-compromised | 1C Lymphoma, B cell (Case 1) CD20 1.jpg
Immunohistochemistry shows that the large tumor cells are strongly and diffusely positive for the B-cell marker CD20.
